National HealthCare Corp.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: US6359061008
USD
136.59
-1.09 (-0.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

10.1 k

Shareholding (Mar 2025)

FII

3.80%

Held by 77 FIIs

DII

60.23%

Held by 38 DIIs

Promoter

0.00%

How big is National HealthCare Corp.?

22-Jun-2025

As of Jun 18, National HealthCare Corp. has a market capitalization of 1,575.57 million and reported net sales of 1,363.30 million with a net profit of 108.13 million over the latest four quarters.

Market Cap: As of Jun 18, National HealthCare Corp. has a market capitalization of 1,575.57 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, National HealthCare Corp. reported net sales of 1,363.30 million and a net profit of 108.13 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 980.16 million and total assets of 1,524.43 million.

Read More

What does National HealthCare Corp. do?

22-Jun-2025

National HealthCare Corporation (NHC) operates in the post-acute healthcare sector, offering skilled nursing, assisted living, independent living, and homecare services. As of March 2025, it reported net sales of $372 million and a net profit of $32 million, with a market cap of approximately $1.58 billion.

Overview:<BR>National HealthCare Corporation (NHC) operates in the post-acute healthcare industry, providing skilled nursing facilities, assisted living, independent living, and homecare programs.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 372 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 32 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 1,575.57 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 16.00 <BR>Dividend Yield: 178.54% <BR>Debt Equity: -0.29 <BR>Return on Equity: 9.90% <BR>Price to Book: 1.57<BR><BR>Contact Details:<BR>Address: 100 E Vine St, MURFREESBORO TN: 37130-3734 <BR>Tel: 1 615 8902020 <BR>Website: https://www.nhccare.com/

Read More

Who are in the management team of National HealthCare Corp.?

22-Jun-2025

As of March 2022, the management team of National HealthCare Corp. includes Non-Executive Chairman Mr. Robert Adams, CEO Dr. Stephen Flatt, Directors Mr. W. Andrew Adams, Dr. J. Paul Abernathy, Mr. Ernest Burgess, and Independent Director Mr. Emil Hassan. They oversee the company's operations and strategic direction.

As of March 2022, the management team of National HealthCare Corp. includes the following individuals:<BR><BR>- Mr. Robert Adams, who serves as the Non-Executive Chairman of the Board.<BR>- Dr. Stephen Flatt, who is the Chief Executive Officer and a Director.<BR>- Mr. W. Andrew Adams, who is a Director.<BR>- Dr. J. Paul Abernathy, who is an Independent Director.<BR>- Mr. Ernest Burgess, who is also an Independent Director.<BR>- Mr. Emil Hassan, who serves as an Independent Director. <BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Read More

Is National HealthCare Corp. overvalued or undervalued?

20-Sep-2025

As of August 5, 2025, National HealthCare Corp. is fairly valued with a P/E ratio of 16, lower than the industry average of 18.51, and despite strong growth potential indicated by a PEG ratio of 0.34, it has underperformed the S&P 500 with a return of -3.46% over the past year.

As of 5 August 2025, the valuation grade for National HealthCare Corp. has moved from attractive to fair. The company appears to be fairly valued based on its current metrics. The P/E ratio stands at 16, while the industry average P/E is notably higher at approximately 18.51, indicating that National HealthCare is trading at a discount relative to its peers. Additionally, the EV to EBITDA ratio is 8.72, which is lower than the peer average of 9.12, further supporting the fair valuation stance.<BR><BR>In comparison to its peers, Universal Health Services, Inc. has a P/E of 9.21, while Chemed Corp. is significantly more expensive with a P/E of 56.91. The PEG ratio for National HealthCare is 0.34, suggesting strong growth potential relative to its price. Over the past year, National HealthCare has underperformed the S&P 500, returning -3.46% compared to the index's 17.14%, which may indicate some market skepticism about its future growth prospects.

Read More

Is National HealthCare Corp. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, National HealthCare Corp. shows a bullish technical trend supported by positive MACD and moving averages, despite mixed signals from Bollinger Bands and KST, while underperforming the S&P 500 recently but outperforming it over the past month and three years.

As of 3 October 2025, the technical trend for National HealthCare Corp. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting the positive trend. Daily moving averages also indicate a bullish stance. While the Bollinger Bands show a mildly bullish trend on both weekly and monthly time frames, the KST is bullish weekly but mildly bearish monthly, suggesting some mixed signals. The Dow Theory indicates a mildly bullish trend on the weekly chart with no trend on the monthly. <BR><BR>In terms of performance, the stock has underperformed the S&P 500 over the past week and year, but it has outperformed over the past month and three years. Overall, the current technical stance is bullish, with moderate strength driven by the MACD and moving averages.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Hospital

stock-summary
Market cap

USD 1,797 Million (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

105.09%

stock-summary
Debt Equity

-0.30

stock-summary
Return on Equity

9.50%

stock-summary
Price to Book

1.76

Revenue and Profits:
Net Sales:
373 Million
(Quarterly Results - Jun 2025)
Net Profit:
24 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
18.62%
0%
18.62%
6 Months
30.86%
0%
30.86%
1 Year
7.51%
0%
7.51%
2 Years
58.27%
0%
58.27%
3 Years
127.35%
0%
127.35%
4 Years
110.53%
0%
110.53%
5 Years
104.6%
0%
104.6%

National HealthCare Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.36%
EBIT Growth (5y)
30.04%
EBIT to Interest (avg)
54.58
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.26
Tax Ratio
25.13%
Dividend Payout Ratio
37.03%
Pledged Shares
0
Institutional Holding
64.13%
ROCE (avg)
13.53%
ROE (avg)
7.00%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.63
EV to EBIT
12.02
EV to EBITDA
8.72
EV to Capital Employed
1.90
EV to Sales
0.99
PEG Ratio
0.34
Dividend Yield
171.38%
ROCE (Latest)
15.79%
ROE (Latest)
9.90%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Bullish
Bullish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 57 Schemes (35.91%)

Foreign Institutions

Held by 77 Foreign Institutions (3.8%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.35% vs 1.06% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -25.39% vs 438.33% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "373.10",
          "val2": "371.80",
          "chgp": "0.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "38.20",
          "val2": "50.90",
          "chgp": "-24.95%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.00",
          "val2": "2.10",
          "chgp": "-4.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.80",
          "val2": "1.90",
          "chgp": "-5.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "24.10",
          "val2": "32.30",
          "chgp": "-25.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "72.90%",
          "val2": "107.20%",
          "chgp": "-3.43%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 12.23% vs 5.72% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 56.36% vs 226.50% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,251.50",
          "val2": "1,115.10",
          "chgp": "12.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "106.90",
          "val2": "88.00",
          "chgp": "21.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.10",
          "val2": "0.30",
          "chgp": "1,266.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "12.70",
          "val2": "20.20",
          "chgp": "-37.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "102.10",
          "val2": "65.30",
          "chgp": "56.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "51.90%",
          "val2": "41.20%",
          "chgp": "1.07%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
373.10
371.80
0.35%
Operating Profit (PBDIT) excl Other Income
38.20
50.90
-24.95%
Interest
2.00
2.10
-4.76%
Exceptional Items
1.80
1.90
-5.26%
Consolidate Net Profit
24.10
32.30
-25.39%
Operating Profit Margin (Excl OI)
72.90%
107.20%
-3.43%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.35% vs 1.06% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -25.39% vs 438.33% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,251.50
1,115.10
12.23%
Operating Profit (PBDIT) excl Other Income
106.90
88.00
21.48%
Interest
4.10
0.30
1,266.67%
Exceptional Items
12.70
20.20
-37.13%
Consolidate Net Profit
102.10
65.30
56.36%
Operating Profit Margin (Excl OI)
51.90%
41.20%
1.07%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 12.23% vs 5.72% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 56.36% vs 226.50% in Dec 2023

stock-summaryCompany CV
About National HealthCare Corp. stock-summary
stock-summary
National HealthCare Corp.
Hospital
National HealthCare Corporation (NHC) is engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The Company is engaged in the post-acute healthcare industry segment. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home healthcare services. It has interest in a hospice care business that services NHC owned healthcare centers and others. In addition, it provides management services, accounting and financial services, as well as insurance services to third-party operators of healthcare facilities. As of December 31, 2016, it owned the real estate of 13 healthcare properties and leased these properties to third-party operators. As of December 31, 2016, it operated in 10 states, and its owned and leased properties are located in various parts of the United States.
Company Coordinates stock-summary
Company Details
100 E Vine St , MURFREESBORO TN : 37130-3734
stock-summary
Tel: 1 615 8902020
stock-summary
Registrar Details